Kalytera Therapeutics Inc. (QB)
Ticker Symbol: USOTC:KALTF
OTC Market Tier: OTCQB
CIK Number: 0001395961
Security Type: Ordinary Shares
KALTF Address: 4040 Civic Center Drive
Suite 200
San Rafael, California 94903
KALTF Country: USA
KALTF Phone: (888) 861-2008
KALTF Fax #: N/A
Website: http://www.kalytera.co
Description: Kalytera Therapeutics is a clinical-stage pharmaceutical company pioneering the development of a next generation of cannabinoid therapeutics. Through its proven leadership, drug development expertise, and intellectual property portfolio, Kalytera seeks to establish a leading position in the development of novel cannabinoid medicines for a range of important unmet medical needs, with an initial focus on Graft versus Host Disease ("GvHD"). Kalytera is also developing a new class of proprietary cannabidiol ("CBD") therapeutics. CBD is a remarkable compound that has shown activity against a number of pharmacological targets. However, there are limitations associated with natural CBD, including its poor oral bioavailability. Kalytera is developing innovative CBD formulations and prodrugs in an effort to overcome these limitations, and to target specific disease sites within the body. Kalytera has filed composition of matter and method of use patents covering its novel inventions, with the goal of limiting future competition.
SIC Code / Description: 2834 / Pharmaceutical preparations
Shares Authorized:
Shares Outstanding: 499,335,301
Shares Outstanding Date: 05/22/2019
Shares Holder Count: 85
Shares Holder Date: 06/20/2018
Market Capitalization: $ 14,680,457.85
Key Executives: Ronald Erickson - Dir.
Jeffrey Paley - Dir.
Robert Farrell - CEO
Victoria Rudman - Interim CFO
Gary Leong - Dir.
Number of Employees: N/A
Incorporation State: BC
Incorporation Country: Canada
Incorporation Year: 2014
Auditor: Kost Forer Gabbay & Kasierer
Auditor Address: 3 Aminadav St.
Auditor Website: N/A
IR Firm: N/A
Legal Counsel: Torys LLP
Legal Counsel Address: Suite 3000
Suite 3000
Toronto, ONT M5K 1N2
Legal Counsel Website: N/A
Fiscal Year End: 12/31
Reporting Status: International Reporting
Bankrupt: No
Shell: No
Audit Status: Yes
ADR Ratio: N/A
Transfer Agent: TSX Trust
TA Address: 301 - 100 Adelaide Street West
Toronto, ONT M5H 4H1
Depository Website: N/A
SHO Flag: N/A
3210 Flag: N/A
Short Volume: 59,732
Short Date: 06/28/2019
Closing MMID: 8
BFCMmid: 5
Tier ID: 10
Status: Active

Your Recent History
Kalytera T..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.